Associate Health Minister Peter Dunne has approved the use of a cannabis-based product to treat a severe case of Tourette's Syndrome.
Today's approval of Aceso Calm spray, a non-pharmaceutical grade product with a low THC content, followed an application from the patient's treating consultant.
While a review of the guidelines for approving such products is under way, the application met seven of the eight existing guideline criteria, providing a good level of information about the product, its efficacy and why it was being applied for.
"The application was comprehensive, innovative and considered. The director of mental health and the acting director of public health recommended its approval," Mr Dunne said.
"Although it has been suggested that the information requirements for applications are too stringent, an aspect I expect the current guidelines review will look into, the application I received today suggests that they are not an impediment to robust, clinician-led, assessment-based approaches."